We work to design and deliver cancer pathways that improve life outcomes for our patients using new proven technology, advanced techniques and approved treatment protocols.
We are at the forefront of the introduction of innovative and advanced radiation therapy techniques. Our centres are equipped with the latest-generation linear accelerators and new modalities are offered as standard.
Elekta Unity MR-Linac
Magnetic resonance image-guided radiation therapy, or MRIgRT, is the most exciting new development in advanced radiation therapy for years. MR-Linac technology places our team at the forefront of patient-centric cancer care.
DCISionRT is a molecular assay for women with ductal carcinoma in situ (DCIS), assessing the 10-year risk of recurrence or development of invasive breast cancer, and the benefit of radiation therapy in reducing that risk for your patients.